Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gwenael Le Moal is active.

Publication


Featured researches published by Gwenael Le Moal.


Clinical Infectious Diseases | 2003

Meningitis Due to Capnocytophaga canimorsus after Receipt of a Dog Bite: Case Report and Review of the Literature

Gwenael Le Moal; C. Landron; Ghislaine Grollier; René Robert; Christophe Burucoa

We describe a case of meningitis due to Capnocytophaga canimorsus and review 18 cases with attention to risk factors, clinical features, diagnosis, treatment, and outcome. In most of the reported cases, contact with dogs and predisposing factors were found. Clinical manifestations and the findings of examinations of cerebrospinal fluid specimens were similar to those of classic bacterial meningitis; however, the mortality rate for C. canimorsus meningitis very low when compared with the rate for C. canimorsus septicemia (5% vs. 30%).


Scandinavian Journal of Infectious Diseases | 2003

Characteristics of brain abscess with isolation of anaerobic bacteria

Gwenael Le Moal; C. Landron; Ghislaine Grollier; Benoit Bataille; Pascal Nassans; B. Becq-Giraudon

In view of its localization, brain abscess (BA) usually requires medical and surgical care. A broad spectrum of bacteria is involved. Recent reports stress the increasing frequency of anaerobes, but their impact has not been well evaluated. A retrospective review was conducted of all episodes of documented BA admitted in a tertiary-care hospital over a 10 y period. BA due to anaerobic bacteria (group A) were compared with other cases (group B) to determine the frequency and eventual characteristics of BA with isolated anaerobic bacteria. Between 1991 and 2000, BA were diagnosed in 42 patients (28M, 14F, mean age 54.6 y). No differences in clinical features and laboratory findings were found between patients with BA caused by anaerobic (n=22) and only aerobic (n=20) bacteria. Using appropriate microbiological techniques, 41 anaerobic bacteria strains were isolated in 22 of 42 patients (52.4%) with BA. Anaerobic bacteria were associated with aerobic strains in 5 patients (12%), whereas in 17 patients (40.5%) only anaerobic strains were isolated in cerebral puncture cultures. The most frequently isolated species were Fusobacterium nucleatum (n=14), Prevotella sp. (n=8), Actinomyces sp. (n=6) and Bacteroides sp. (n=4). Compared with group B, group A had more cases of a single abscess (p=0.03) and ear, nose and throat (ENT) as a source of infection (p=0.04), and seemed to have a better outcome (p=0.07). These results emphasize the important role that anaerobic bacteria play in BA. The presence of such pathogens must be evoked when faced with a single abscess, an ENT infection, or both. Therapy should take into account this high frequency.


Scandinavian Journal of Infectious Diseases | 2001

Rupture of a primary aortic aneurysm infected with Shewanella alga

Marc Paccalin; Ghislaine Grollier; Gwenael Le Moal; Fatima Rayeh; Christophe Camiade

Bacteria of the genus Shewanella are rarely implicated in bacteremia. We report a case of rupture of a primary aneurysm infected with Shewanella alga.


Scandinavian Journal of Infectious Diseases | 2004

Risk factors analysis for pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia

Sabrina Imbert; C. Godet; Catherine Kauffmann; Stéphanie Ragot; Gwenael Le Moal; P. Roblot; Marie Helene Rodier; René Robert; B. Becq-Giraudon; Francois Guilhot

A retrospective matched case-control investigation was conducted to assess risk factors suggesting Pneumocystis jiroveci pneumonia (PCP) when pneumonia occurs in adult patients with haematological malignancies. Cases and controls included were HIV-negative, presented with pneumonia and had benefited from a bronchoalveolar lavage (BAL). The presence of Pneumocystis jiroveci cysts was systematically investigated by cytochemical staining and/or immunofluorescence. Cases were patients with Pneumocystis jiroveci cysts isolated on BAL fluid (n=31, mean age 51±14 y; range 20–73 y). Controls were patients without Pneumocystis jiroveci cysts (n=62, mean age 54±13 y; range 25–75 y) and were matched to case patients by age and y of pneumonia diagnosis. Statistical analysis indicated that the following factors were associated with PCP: vincristine (p=0.009, odds ratio (OR)=2.11, 95% confidence interval (CI): 1.19–3.72), a daily corticosteroid therapy for more than 1 month (p=0.05) during the past y, and a lymphocyte count less than 0.5×109/l on the d of pneumonia diagnosis (p=0.04). Clinicians should be aware, in order to evoke this diagnosis when pneumonia occurs in patients with these risk factors. The goal of this exploratory study was to identify risk factors that could eventually be further investigated by a larger prospective multicentre study.


Scandinavian Journal of Infectious Diseases | 2001

Central venous catheter-related infection due to Comamonas testosteroni in a woman with breast cancer.

Gwenael Le Moal; Marc Paccalin; Jp Breux; P. Roblot; B. Becq-Giraudon

A 75-y-old woman with breast cancer presented with bacteremia due to Comamonas testosteroni. Evolution was favorable following adapted antimicrobial therapy and removal of a central venous catheter. This germ seems to be a rare pathogen; as reported in the literature, it is mostly encountered in patients with predisposing factors.A 75-y-old woman with breast cancer presented with bacteremia due to Comamonas testosteroni. Evolution was favorable following adapted antimicrobial therapy and removal of a central venous catheter. This germ seems to be a rare pathogen; as reported in the literature, it is mostly encountered in patients with predisposing factors.


Scandinavian Journal of Infectious Diseases | 2014

Pneumocystis jirovecii pneumonia in HIV-negative patients: A prospective study with focus on immunosuppressive drugs and markers of immune impairment

Gwenael Le Moal; C. Kauffmann-Lacroix; Frederic Bastides; David Boutoille; Renaud Verdon; Cendrine Godet; Pierre Tattevin

Abstract Pneumocystis jirovecii pneumonia (PCP) is emerging in HIV-negative patients, for whom the prognosis is significantly worse than in HIV-infected patients and risk factors are poorly characterized. We performed an observational, multi-centre, prospective study of 56 consecutive cases of documented PCP in HIV-negative patients, and found that: (1) the main underlying conditions were haematological malignancies (43%), solid tumours (25%), inflammatory diseases (20%), and solid organ transplantation (7%); (2) most patients (80%) had received prolonged corticosteroids, with a mean daily dose of 47.3 ± 32.8 mg equivalent prednisone when PCP was diagnosed, and a mean cumulative dose of 5807 ± 5048 mg over the last 12 months; and (3) the median CD4 cell count was 0.12 × 109/l (range 0.0–1.42), with a median CD4/CD8 ratio of 1.32 (0.0–6.4). These findings may be used to better target PCP prophylaxis according to the level of risk and contribute to decrease the burden of PCP in HIV-negative patients.


Mycoses | 2015

Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review

Cendrine Godet; Véronique Goudet; François Laurent; Gwenael Le Moal; V. Gounant; Jean-Pierre Frat; Estelle Cateau; Jacques Cadranel

Over the past 10 years the incidence of Aspergillus spp. has significantly increased, and it is now the most widespread air transmission fungal pathogen in developed countries. Whatever the clinical expression of the pulmonary disease and despite recent progress in antifungal drug therapy, morbidity and mortality related to aspergillosis lung disease still constitute a serious threat for immunosuppressed or mildly immunocompromised patients. Moreover, the treatments currently used have many limitations due to adverse effects and drug interactions. Finally, subjects exposed to azoles present an increased risk of Aspergillus‐resistant strain emergence. We have reported five cases with aspergillosis lung diseases that were either difficult to control or in which patients had a contra‐indication to triazole therapy, but which showed durable improvement following the administration of nebulised liposomal amphotericin B. Our alternative strategy could be of interest for patients with aspergillosis lung disease who otherwise cannot be conventionally treated by triazoles.


Scandinavian Journal of Infectious Diseases | 2002

Infective endocarditis after transrectal prostatic biopsy.

Gwenael Le Moal; Jacques Irani; Marc Paccalin; P. Roblot; Ghislaine Grollier; B. Becq-Giraudon

We report the first case of infective endocarditis secondary to transrectal prostatic biopsy, occurring 2 weeks later in a patient with no obvious risk factors. Enterococcus faecalis was isolated in blood and urine cultures. This case suggests that infective endocarditis can be associated with transrectal procedures.


Scandinavian Journal of Infectious Diseases | 2002

Central Venous Catheter-related Infection Due to Agrobacterium radiobacter: A Report of 2 Cases

C. Landron; Gwenael Le Moal; Bernadette Grignon; Anthony Bonnin; B. Becq-Giraudon

We report 2 cases of Agrobacterium radiobacter bacteremia in immunocompromised patients. Removal of the central venous catheter and administration of antimicrobial therapy led to favorable outcomes in both patients. Infections due to A. radiobacter are rare and usually occur in patients with predisposing factors.


Scandinavian Journal of Infectious Diseases | 2004

Cat-scratch disease presenting as a breast mass

C. Godet; Gwenael Le Moal; P. Roblot; Jean Pierre Frat; B. Becq-Giraudon

The case of a 14-y-old girl who presented with a mass in her left breast after having contact with a guinea pig is presented. The diagnosis of cat-scratch disease was made by detection of Bartonella henselae DNA by PCR analysis of abscess aspirate.

Collaboration


Dive into the Gwenael Le Moal's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

P. Roblot

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

P. Roblot

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Ghislaine Grollier

Institut national de la recherche agronomique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge